Kerry Blackham, DO
Geriatric Medicine · Philip, SDNPI 1922014273
Payments from drug & device makers
Across 69 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$202
- Amgen$156
- Novartis$116
- Lilly USA, LLC$113
- AstraZeneca$90
- E.r. Squibb & Sons, L.L.C.$82
- plus $334 from 10 others
What the payments were for
- Food & beverage$1,094100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $202 |
| Amgen | 10 | $156 |
| Novartis | 7 | $116 |
| Lilly USA, LLC | 7 | $113 |
| AstraZeneca | 5 | $90 |
| E.r. Squibb & Sons, L.L.C. | 5 | $82 |
| Pfizer | 5 | $70 |
| Avanir Pharmaceuticals, Inc. | 4 | $59 |
| Exact Sciences | 3 | $48 |
| Boehringer Ingelheim | 3 | $35 |
| Boston Scientific | 1 | $31 |
| Novo Nordisk | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Smith+Nephew | 1 | $17 |
| Organogenesis Inc. | 1 | $12 |
How this compares
Too few geriatric medicine providers in South Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 145 | $69,898 |
| OzempicSemaglutide | 31 | $35,014 |
| MounjaroTirzepatide | 31 | $34,536 |
| JardianceEmpagliflozin | 36 | $26,266 |
| XareltoRivaroxaban | 23 | $12,856 |
| Fentanyl | 68 | $11,186 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $10,264 |
| Spiriva RespimatTiotropium Bromide | 18 | $10,119 |
| MultaqDronedarone Hcl | 13 | $9,847 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 34 | $7,525 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $7,256 |
| FarxigaDapagliflozin Propanediol | 16 | $7,187 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 20 | $6,372 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 11 | $6,263 |
| EntrestoSacubitril/Valsartan | 19 | $6,051 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo | $70 | $76,270165 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Synjardy Xr, Stiolto Respimat | $35 | $48,43976 claims |
| Novo NordiskOzempic | $22 | $35,01431 claims |
| Lilly USA, LLCMounjaro | $113 | $34,53631 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort, Brilinta | $90 | $27,83574 claims |
| Johnson & JohnsonXarelto | $202 | $12,85623 claims |
| NovartisEntresto | $116 | $6,05119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few geriatric medicine providers in South Dakotaon file to place this against a meaningful peer group, so we don't.
Other geriatric medicine in Philip
- Terry WeaverWessington Springs$441
- Jack HigginsSpearfish$116
- Joseph ReesSioux Falls$103
- Kamonchanok KijsirichareanchaiSioux Falls$28
- Priscilla BadeRapid City$19
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.